About this trial
Based on mass spectrometry flow method, this study analyzed the typing of new T, B, NK and DC cell subsets in peripheral blood of common autoimmune diseases and their correlation with disease activity, aiming at establishing an early screening and diagnosis model of autoimmune diseases.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Male or female, and aged 18-70 at the time of screening interview (inclusive).
The diagnosis of each disease meets the following standards - Systemic lupus erythematosus: 1997 ACR lupus classification standard
Behcet's disease: 2014 ICBD Behcet's disease classification standard
ANCA-associated vasculitis: 1990 American College of Rheumatology Classification Standard
Disqualifiers
None
Trial population
The patients are in a state of disease activity and do not use biological agents.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
proportion of immune cell subsets in peripheral blood.
Immune cell subsets include T cell, B cell, NK cell, Treg cell, Tfh cell, CLA+Treg cell, Tfr cell, Th1 cell, Th2 cell, Th17 cell and some unnamed cell subsets.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Peking University People's Hospital
Lead sponsor
National Natural Science Foundation of China
Collaborator
Zhejiang PuLuoTing Health Technology Co., Ltd.
Collaborator
This trial is not recruiting at the moment. You can still explore other options: